Seto Takashi | Division Of Respiratory Diseases Kumamoto Regional Medical Center
スポンサーリンク
概要
関連著者
-
Seto Takashi
Division Of Respiratory Diseases Kumamoto Regional Medical Center
-
Eguchi Kenji
Division Of Medical Oncology Department Of Internal Medicine Teikyo University School Of Medicine
-
Seto Takashi
Division of Medical Oncology, Tokai University School of Medicine
-
Inoue Fumiko
Division Of Respiratory Diseases Kumamoto Regional Medical Center
-
Eguchi Kenji
Division Of Pulmonary Medicine Tokai University School Of Medicine
-
Mine Tetsuya
Division Of Gasroenterology And Hepatology Department Of Internal Medicine University Of Tokai Schoo
-
TAKEZAKO Yoriko
Division of Respiratory Diseases, Kumamoto Regional Medical Center
-
NAKAMURA Hiroko
Division of Respiratory Diseases, Kumamoto Regional Medical Center
-
TAKEDA Kayo
Division of Respiratory Diseases, Kumamoto Regional Medical Center
-
SEMBA Hiroshi
Division of Respiratory Diseases, Kumamoto Regional Medical Center
-
Takeda Kayo
Division Of Respiratory Diseases Kumamoto Regional Medical Center
-
Semba Hiroshi
Division Of Respiratory Diseases Kumamoto Regional Medical Center
-
Takezako Yoriko
Division Of Respiratory Diseases Kumamoto Regional Medical Center
-
Ito Akemi
Division Of Gastroenterology And Hepatology Department Of Internal Medicine Tokai University School
-
Nakamura Hiroko
Division Of Respiratory Diseases Kumamoto Regional Medical Center
-
Mine Tetsuya
Division of Gastroenterology, Tokai University School of Medicine
-
Seki Nobuhiko
Division of Medical Oncology, Tokai University School of Medicine
-
Watanabe Kennichi
Division of Gastroenterology, Tokai University School of Medicine
-
Shibakuki Reishi
Division of Medical Oncology, Tokai University School of Medicine
-
Uematsu Kazutsugu
Division of Medical Oncology, Tokai University School of Medicine
-
Nakamura Hiroko
Division of Hematology, Department of Medicine, Juntendo University Nerima Hospital, Japan
著作論文
- Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer : a phase II study
- Irreversible Imatinib-induced Pneumonitis following Long-term Imatinib Administration